Agilent and Proscia Partner on Comprehensive Digital Pathology System
Agilent Technologies announced a multi-year distribution agreement with Proscia to offer a comprehensive digital diagnostic pathology system.
Read More
Search Results for: covid-19
Exhaled Breath Could Diagnose COVID More Accurately
A recent University of Michigan study suggests that a patient’s breath might hold the key to a more precise diagnosis of COVID
Read More
FDA Grants InBios First Marketing Rights for Anthrax POC Test
InBios has been granted the U.S. Food and Drug Administration’s (FDA) first marketing rights for an anthrax point-of-care (POC) test.
Read More
Next-Generation Sequencing Is Revolutionizing Precision Medicine
Automated NGS platforms can help determine if a patient is fit for a targeted therapy, enabling more effective precision medicine.
Read More
Will CPT Codes Drive Digital Pathology Adoption?
Proscia Co-founder and Chief Product Officer Nathan Buchbinder outlines why digital pathology adoption will be aided by new CPT codes.
Read More